Table 3: Laboratory data change of renal and hepatic functions markers in ESRD and chronic HD patients treated with AG.
|
Before |
After |
|||
3rd month |
6th month |
One year |
|||
Cr (mg/dL) |
1 p |
7.0 ± 2.2 |
8.2 ± 2.3 |
8.2 ± 2.0 |
8.0 ± 2.3 |
|
2 p |
7.3 ± 2.0 |
7.8 ± 1.5 |
8.1 ± 1.7 |
7.8 ± 1.7 |
BUN (mg/dL) |
1 p |
42 ± 16 |
54 ± 23 |
53 ± 15 |
52 ± 16 |
|
2 p |
39 ± 11 |
56 ± 12 |
59 ± 10 |
55 ± 15 |
UA (mg/dL) |
1 p |
5.9 ± 1.6 |
6.8 ± 1.8 |
6.7 ± 1.9 |
6.6 ± 1.4 |
|
2 p |
5.3 ± 1.0 |
5.6 ± 0.7 |
5.8 ± 0.9 |
5.7 ± 1.1 |
c-Ca (mg/dL) |
1 p |
9.0 ± 0.6 |
9.3 ± 0.1 |
9.0 ± 0.3 |
9.6 ± 0.9 |
|
2 p |
9.3 ± 1.0 |
9.1 ± 0.9 |
9.0 ± 0.5 |
9.1 ± 0.6 |
P (mg/dL) |
1 p |
4.2 ± 2.2 |
4.0 ± 1.2 |
4.1 ± 1.1 |
4.3 ± 0.9 |
|
2 p |
4.8 ± 2.1 |
4.6 ± 1.2 |
5.1 ± 1.1 |
4.6 ± 1.4 |
AST (IU/L) |
1 p |
11 ± 1 |
10 ± 2 |
10 ± 2 |
10 ± 1 |
|
2 p |
17 ± 6* |
20 ± 6* |
18 ± 3* |
17 ± 3* |
ALT (IU/L) |
1 p |
6 ± 2 |
7 ± 3 |
6 ± 2 |
5 ± 2 |
|
2 p |
10 ± 2* |
11 ± 1* |
11 ± 2* |
10 ± 3* |
The data are expressed as mean ± standard deviation; *: P < 0.05 compared between the one powder and the two powders groups
Cr: Creatinine; BUN: Blood urea nitrogen; UA: Urea acid; c-Ca: corrected Calcium; P: Phosphate; ASL: Aspartate aminotransferase; ALT: Alanine aminotransferase; 1 p: One powder AG; 2 p: Two powders AG